Effect of gestational protein restriction on left ventricle hypertrophy and heart angiotensin II signaling pathway in adult offspring rats

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Fourth Annual Symposium in Virology

What a pleasure it is to take part in welcoming you to this Fourth Annual Symposium in Virology. Such a tremendous program lies ahead! And how pleased and proud we are that this year's symposium is a special tribute to our colleague Dr. James Van Etten, Professor of Plant Pathology in our Institute of Agriculture and Natural Resources here at the University of Nebraska-Lincoln, who last-year was elected to membership in the National Academy of Sciences.

Welcome: Fourth Annual Water Law, Policy and Science Conference

It was Mark Twain who, in 1884, penned the words, and I quote, "Whiskey is for drinking; water is for fighting over."

CLOSING REMARKS - FOURTH VERTEBRATE PEST CONFERENCE

On behalf of the California Vertebrate Pest Committee, which sponsors these conferences, I wish to thank all of the speakers for their contribution to the program and the session chairmen who kept the meeting moving so smoothly. We would like to extend a special thanks to the speakers and participants who have come from other countries to share with us some of their knowledge concerning vertebrate pest problems and their solutions. Hopefully, the acquaintances made here and the exchange of information with our colleagues from distant places will be the beginning of long-lasting friendships and will foster better communications between those with mutual interests.

Cardiovascular effects of the microinjection of L-proline into the third ventricle or the paraventricular nucleus of the hypothalamus in unanesthetized rats

We investigated the cardiovascular effects of the microinjection of L-proline (L-Pro) into the third ventricle (3V) and its peripheral mechanisms. Different doses of L-Pro into the 3V caused dose-related pressor and bradycardiac responses. The pressor response to L-Pro injected into the 3V was potentiated by intravenous pretreatment with the ganglion blocker pentolinium (5 mg/kg), thus excluding any significant involvement of the sympathetic nervous system. Because the response to the microinjection of L-Pro into the 3V was blocked by intravenous pretreatment with the V1-vasopressin receptor antagonist dTyr(CH2)5(Me)AVP (50 mu g/kg), it is suggested that these cardiovascular responses are mediated by a vasopressin release. The pressor response to the microinjection of L-Pro into the 3V was found to be mediated by circulating vasopressin, so, given that the paraventricular nucleus of the hypothalamus (PVN) is readily accessible from the 3V, we investigated whether the PVN could be a site of action for the L-Pro microinjected in the 3V. The microinjection of L-Pro (0.033 mu moles/0.1 mu l) into the PVN caused cardiovascular responses similar to those of injection of the 3V and were also shown to be mediated by vasopressin release. In conclusion, these results show that the microinjection of L-Pro into the 3V causes pressor and bradycardiac responses that could involve stimulation of the magnocellular cells of the PVN and release of vasopressin into the systemic circulation. Also, because the microinjection of L-Pro into the PVN caused a pressor response, this is the first evidence of cardiovascular effects caused by its injection in a supramedullary structure. (c) 2012 Wiley Periodicals, Inc.